Esperion Therapeutics Inc (ESPR)
Gross Profit Growth
60.38%
TTM · Period ending:
ESPR Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported60.38%period ending
Latest reported60.38%period ending
ESPR TTM Gross Profit YoY % (-86.05% → 60.38%)
Year-over-year change
High-resolution chart · PNG
ESPR gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 60.3764% | |
| -1.4914% | |
| -32.5102% | |
| -27.3448% | |
| -9.8591% | |
| 260.9194% | |
| 260.1372% | |
| 286.463% | |
| 280.0986% | |
| 50.6288% | |
| 51.5008% | |
| 45.0176% | |
| -29.0665% | |
| -24.4777% | |
| -28.5802% | |
| -28.3022% | |
| -69.6144% | |
| -71.473% | |
| -65.6277% | |
| -56.1865% | |
| 284.2969% | |
| 926.3479% | |
| 24.1004% | |
| -14.3677% | |
| -181.3849% | |
| -309.8183% | |
| 153.782% | |
| 166.1012% | |
| 181.1682% | |
| 108.7979% | |
| 100% | |
| 100% | |
| 100% | |
| 100% | |
| 32.1429% | |
| -86.0481% |